免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

TrueView 200 Pro-US 样本射线摄影系统(TrueView 200 Pro-US)

K号: K230136 · 2023-04-24

决定日期2023-04-24
产品代码MWP
咨询委员会RA
决定实质等同

器械摘要

TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US) is the device name listed in this FDA 510(k) record. The listed applicant is Compai Healthcare (Suzhou) Co.,Ltd. It received FDA 510(k) clearance on 2023-04-24 under 510(k) number K230136. The device is classified under product code MWP. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US)?

TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US) is a medical device that received FDA 510(k) clearance on 2023-04-24. The listed applicant is Compai Healthcare (Suzhou) Co.,Ltd. The 510(k) number is K230136.

When did TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US) receive FDA 510(k) clearance?

TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US) received FDA 510(k) clearance on 2023-04-24, under 510(k) number K230136.

Who is the listed applicant for TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US)?

The FDA 510(k) record lists Compai Healthcare (Suzhou) Co.,Ltd as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US)?

The FDA product code for TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US) is MWP.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Compai Healthcare (Suzhou) Co.,Ltd为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:MWP)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑